Welcome to Mesothelioma.net - Turning Hope and Faith into Action.

MultiModality Mesothelioma Treatment Still Seen as Best

The search for an effective treatment protocol for the rare and deadly form of cancer known as mesothelioma provides a challenge to researchers and physicians alike. Now a recent study indicates that the multi modality treatment approach that has gained popularity in the last several years is seen as one of the most successful options.

According to a collaborative research project conducted by doctors in England and Italy, the use of a multi-pronged approach that includes surgery, pleural lavage, systemic chemotherapy and radiotherapy provides patients diagnosed with malignant mesothelioma with the longest overall survival rates, with median survival extending far beyond what is seen with single modality approaches. The physicians followed the progress of over 100 patients who received treatment over a ten year period at the University of Milan or at one of two London hospitals. Of these patients, who were largely male, 75% had been diagnosed with the most common cell type of mesothelioma, known as epithelioid mesothelioma. All of the patients were provided with a variety of treatments, including a surgical procedure known as pleurectomy/decortication, which spares the lung but removes the diseased pleural lining and other impacted tissue. Following the surgery they were also all provided with pleural lavage, a process in which heated povidone iodine was used to rinse out the surgical site. This solution is frequently used as a surgical disinfectant, and studies have shown that it may have the ability to kill cancer cells left behind after surgery.

All of the patients in the survey were also provided with both radiation therapy and chemotherapy, though there were differences in whether those treatments were provided pre or post surgically. In all 102 cases, the patients all had a 30-day survival, with approximately one in three experiencing some form of complication in the aftermath of their surgery. Remarkably, a follow up on the patients at the five year mark revealed that almost 25% were still alive, a statistic that goes well beyond expectations. Because mesothelioma is an aggressive cancer that is generally not identified until it has already reached an advanced stage, most patients die within one year of diagnosis, but in this group of patients who all submitted to multiple modality therapies, the median survival rate was two years and eight months. Those who had been identified with epithelioid mesothelioma had an even more encouraging median survival of just shy of three years, and almost one third were still alive at the five year mark.

Though physicians still feel that they need more research as to whether to provide chemotherapy and radiation therapy before or after surgery, they are encouraged by this study’s results.

Terri Oppenheimer

Terri Oppenheimer is an experienced blog writer, editor, and proofreader. She graduated from the College of William and Mary with a degree in English. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of expertise include health, medical research, and law.

Get Your FREE Resources Sent Overnight

  • New treatment options
  • Veterans benefits & claims
  • $30 Billion asbestos trust fund information

– Or Call –

Site Navigation

Where can I

Get Additional Help?

For over 15 years, we’ve provided the best FREE resources to mesothelioma patients and loved ones. Our resources include information on the leading treatment options and best doctors in your area; lessons learned from survivors; claims and benefits specifically for Veterans; and how to access your share of billions of dollars in trust fund money.

Get Your FREE Resources Sent Overnight

  • New Treatment Options
  • Veteran's Benefits & Claims
  • $30 Billion Asbestos Trust Fund Information

– Or Call –

We are here to help you


If you've been diagnosed with asbestos-related cancer, contact us at 1-800-692-8608 to find out if you are eligible to receive compensation. You can also fill out the form above to receive FREE information.

Quick Compensation - $30 Billion Trusts
$30 Billion Asbestos Trusts
Get Started